Jarrod Mousa

Affiliations: 
2015-2017 Pediatrics Vanderbilt University School of Medicine, Nashville, TN, United States 
Google:
"Jarrod Mousa"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Abu-Shmais AA, Miller RJ, Janke AK, et al. (2024) Potent HPIV3-neutralizing IGHV5-51 Antibodies Identified from Multiple Individuals Show L Chain and CDRH3 Promiscuity. Journal of Immunology (Baltimore, Md. : 1950)
Gonzalez KJ, Huang J, Criado MF, et al. (2024) A general computational design strategy for stabilizing viral class I fusion proteins. Nature Communications. 15: 1335
Hendy DA, Lifshits LM, Batty CJ, et al. (2023) Zinc Carnosine Metal-Organic Coordination Polymer as a Potent Broadly Active Influenza Vaccine Platform with In Vitro Shelf-Stability. Molecular Pharmaceutics
Miller RJ, Mousa JJ. (2023) Structural basis for respiratory syncytial virus and human metapneumovirus neutralization. Current Opinion in Virology. 61: 101337
Nagashima K, Mousa JJ. (2023) Epitope Binning of Monoclonal and Polyclonal Antibodies by Biolayer Interferometry. Methods in Molecular Biology (Clifton, N.J.). 2673: 17-32
Dzimianski JV, Han J, Sautto GA, et al. (2023) Structural insights into the broad protection against H1 influenza viruses by a computationally optimized hemagglutinin vaccine. Communications Biology. 6: 454
Gonzalez KJ, Huang J, Criado MF, et al. (2023) A general computational design strategy for stabilizing viral class I fusion proteins. Biorxiv : the Preprint Server For Biology
Nagashima K, Abbadi N, Vyas V, et al. (2023) Adjuvant-Mediated Differences in Antibody Responses to Computationally Optimized Hemagglutinin and Neuraminidase Vaccines. Viruses. 15
Abbadi N, Mousa JJ. (2023) Broadly Protective Neuraminidase-Based Influenza Vaccines and Monoclonal Antibodies: Target Epitopes and Mechanisms of Action. Viruses. 15
Durie IA, Tehrani ZR, Karaaslan E, et al. (2022) Structural characterization of protective non-neutralizing antibodies targeting Crimean-Congo hemorrhagic fever virus. Nature Communications. 13: 7298
See more...